GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Allakos Inc (STU:37Z) » Definitions » Other Stockholders Equity

Allakos (STU:37Z) Other Stockholders Equity : €-0.00 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Allakos Other Stockholders Equity?

Allakos's Other Stockholders Equity for the quarter that ended in Dec. 2024 was €-0.00 Mil.

Allakos's quarterly Other Stockholders Equity increased from Jun. 2024 (€-0.00 Mil) to Sep. 2024 (€0.00 Mil) but then declined from Sep. 2024 (€0.00 Mil) to Dec. 2024 (€-0.00 Mil).

Allakos's annual Other Stockholders Equity declined from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€-0.00 Mil) but then increased from Dec. 2023 (€-0.00 Mil) to Dec. 2024 (€-0.00 Mil).

Allakos Other Stockholders Equity Historical Data

The historical data trend for Allakos's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allakos Other Stockholders Equity Chart

Allakos Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only - - - - -

Allakos Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Allakos Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Allakos Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Allakos's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Allakos Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Allakos Inc (STU:37Z) » Definitions » Other Stockholders Equity
Comparable Companies
NKGN AKTX FNCH NRSN LVTX LEXX XCUR PTN CRIS CDIO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
ALLK:USA
Address
825 Industrial Road, Suite 500, San Carlos, CA, USA, 94070
Website
https://www.allakos.com
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation. Its portfolio consists of antibodies that target receptors, particularly Siglec-6, Siglec-8 and other anti-Siglec antibodies, including some antibodies in preclinical development.

Allakos Headlines

No Headlines